Gaeun Lim, Yunhee Jeong, Seung Hun Lee, Tae Yun Kim, Gun Woo Doh, Hee Taek Kim, Jae-Seok Kim, Shashi Kant Bhatia, Hyung Chul Kim, Yung-Hun Yang
{"title":"聚己二酸丁二酸-对苯二甲酸酯单体的完全利用及乙酰丙酸介导的恶臭假单胞菌和necavidus微生物联合体生产聚羟基丁酸酯。","authors":"Gaeun Lim, Yunhee Jeong, Seung Hun Lee, Tae Yun Kim, Gun Woo Doh, Hee Taek Kim, Jae-Seok Kim, Shashi Kant Bhatia, Hyung Chul Kim, Yung-Hun Yang","doi":"10.1021/acssynbio.6c00263","DOIUrl":null,"url":null,"abstract":"<p>Poly(butylene adipate-<em>co</em>-terephthalate)\r\n(PBAT)\r\nis a biodegradable plastic with enhanced mechanical properties, which\r\ncan serve as a substitute for conventional plastics. However, the\r\nmonomers released during its biodegradation, such as adipic acid (AA),\r\n1,4-butanediol (1,4-BDO), and terephthalic acid (TPA), accumulate\r\ninto the environment or are not simply consumed through central metabolism,\r\nlimiting their resource value. Therefore, designing a single strain\r\nthat can efficiently consume all monomers is challenging. Here, a\r\nconsortium comprising <em>Pseudomonas putida</em> KT2440 harboring <em>tpaK</em>, <em>tphA</em>, and <em>tphB</em> which metabolizes 1,4-BDO and TPA and <em>Cupriavidus necator</em> H16, which converts AA into polyhydroxybutyate\r\n(PHB) via β-oxidation was constructed to convert all PBAT-derived\r\nmonomers into PHB. To enhance polyhydroxyalkanoate production, a levulinic\r\nacid (LA)-producing strain GP101 was added to the consortium, resulting\r\nin 0.75 g/L PHB and 0.20 g/L 4-hydroxybutyrate (4HB) production and\r\nrepresenting a 6.25-fold increase in PHB production compared to that\r\nby the consortium containing <em>P. putida</em> KT2440 that could not produce LA. Optimizing the strain ratio of <em>P. putida</em> KT2440 GP101 to <em>C. necator</em> H16 to 2:1 resulted in maximum production of 0.98 g/L PHB and 0.52\r\ng/L 4HB, and all PBAT-derived monomers were completely disappeared\r\nwithin 30 h. This is the first study to demonstrate complete utilization\r\nof PBAT monomers and valorization into PHB by an LA-mediated microbial\r\nconsortium. This approach reveals controllable and reproducible consortia\r\nbeyond the complex design of a single strain and simple treatment\r\nof each monomer, demonstrating the feasibility of converting PBAT-derived\r\nmonomers into value-added products.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":"15 8","pages":"3369–3381"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Complete Utilization of Poly(butylene Adipate-co-terephthalate) Monomers and Production of Polyhydroxybutyrate by a Levulinic Acid-Mediated Microbial Consortium of Pseudomonas putida and Cupriavidus necator\",\"authors\":\"Gaeun Lim, Yunhee Jeong, Seung Hun Lee, Tae Yun Kim, Gun Woo Doh, Hee Taek Kim, Jae-Seok Kim, Shashi Kant Bhatia, Hyung Chul Kim, Yung-Hun Yang\",\"doi\":\"10.1021/acssynbio.6c00263\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Poly(butylene adipate-<em>co</em>-terephthalate)\\r\\n(PBAT)\\r\\nis a biodegradable plastic with enhanced mechanical properties, which\\r\\ncan serve as a substitute for conventional plastics. However, the\\r\\nmonomers released during its biodegradation, such as adipic acid (AA),\\r\\n1,4-butanediol (1,4-BDO), and terephthalic acid (TPA), accumulate\\r\\ninto the environment or are not simply consumed through central metabolism,\\r\\nlimiting their resource value. Therefore, designing a single strain\\r\\nthat can efficiently consume all monomers is challenging. Here, a\\r\\nconsortium comprising <em>Pseudomonas putida</em> KT2440 harboring <em>tpaK</em>, <em>tphA</em>, and <em>tphB</em> which metabolizes 1,4-BDO and TPA and <em>Cupriavidus necator</em> H16, which converts AA into polyhydroxybutyate\\r\\n(PHB) via β-oxidation was constructed to convert all PBAT-derived\\r\\nmonomers into PHB. To enhance polyhydroxyalkanoate production, a levulinic\\r\\nacid (LA)-producing strain GP101 was added to the consortium, resulting\\r\\nin 0.75 g/L PHB and 0.20 g/L 4-hydroxybutyrate (4HB) production and\\r\\nrepresenting a 6.25-fold increase in PHB production compared to that\\r\\nby the consortium containing <em>P. putida</em> KT2440 that could not produce LA. Optimizing the strain ratio of <em>P. putida</em> KT2440 GP101 to <em>C. necator</em> H16 to 2:1 resulted in maximum production of 0.98 g/L PHB and 0.52\\r\\ng/L 4HB, and all PBAT-derived monomers were completely disappeared\\r\\nwithin 30 h. This is the first study to demonstrate complete utilization\\r\\nof PBAT monomers and valorization into PHB by an LA-mediated microbial\\r\\nconsortium. This approach reveals controllable and reproducible consortia\\r\\nbeyond the complex design of a single strain and simple treatment\\r\\nof each monomer, demonstrating the feasibility of converting PBAT-derived\\r\\nmonomers into value-added products.</p>\",\"PeriodicalId\":26,\"journal\":{\"name\":\"ACS Synthetic Biology\",\"volume\":\"15 8\",\"pages\":\"3369–3381\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2026-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Synthetic Biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acssynbio.6c00263\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/7/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acssynbio.6c00263","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/20 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
Complete Utilization of Poly(butylene Adipate-co-terephthalate) Monomers and Production of Polyhydroxybutyrate by a Levulinic Acid-Mediated Microbial Consortium of Pseudomonas putida and Cupriavidus necator
Poly(butylene adipate-co-terephthalate)
(PBAT)
is a biodegradable plastic with enhanced mechanical properties, which
can serve as a substitute for conventional plastics. However, the
monomers released during its biodegradation, such as adipic acid (AA),
1,4-butanediol (1,4-BDO), and terephthalic acid (TPA), accumulate
into the environment or are not simply consumed through central metabolism,
limiting their resource value. Therefore, designing a single strain
that can efficiently consume all monomers is challenging. Here, a
consortium comprising Pseudomonas putida KT2440 harboring tpaK, tphA, and tphB which metabolizes 1,4-BDO and TPA and Cupriavidus necator H16, which converts AA into polyhydroxybutyate
(PHB) via β-oxidation was constructed to convert all PBAT-derived
monomers into PHB. To enhance polyhydroxyalkanoate production, a levulinic
acid (LA)-producing strain GP101 was added to the consortium, resulting
in 0.75 g/L PHB and 0.20 g/L 4-hydroxybutyrate (4HB) production and
representing a 6.25-fold increase in PHB production compared to that
by the consortium containing P. putida KT2440 that could not produce LA. Optimizing the strain ratio of P. putida KT2440 GP101 to C. necator H16 to 2:1 resulted in maximum production of 0.98 g/L PHB and 0.52
g/L 4HB, and all PBAT-derived monomers were completely disappeared
within 30 h. This is the first study to demonstrate complete utilization
of PBAT monomers and valorization into PHB by an LA-mediated microbial
consortium. This approach reveals controllable and reproducible consortia
beyond the complex design of a single strain and simple treatment
of each monomer, demonstrating the feasibility of converting PBAT-derived
monomers into value-added products.
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.